Patent: 7,722,857
✉ Email this page to a colleague
Summary for Patent: 7,722,857
Title: | Immunoadjuvant |
Abstract: | An immunoadjuvant comprising one kind or two or more kinds of immunostimulating substances carried separately by two or more kinds of different microparticle immunostimulating substance carriers, and comprising at least a combination of (a) an inorganic substance such as microparticle calcium phosphate having a size phagocytizable by cells, and (b) precipitates of a soluble protein and a mucopolysaccharide formed by coacervation as the microparticle immunostimulating substance carriers, which is highly safe and can exhibit potent immunoadjuvant activity. |
Inventor(s): | Ohno; Tadao (Ibaraki, JP), Uchimura; Eiji (Chiba, JP) |
Assignee: | Cell-Medicine, Inc. (Ibaraki, JP) |
Application Number: | 12/159,907 |
Patent Claims: | see list of patent claims |
Details for Patent 7,722,857
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Par Pharmaceutical Companies, Inc. | APLISOL | tuberculin, purified protein derivative | Injection | 103782 | 04/20/1998 | ⤷ Try a Trial | 2040-01-28 |
Sanofi Pasteur Limited | TUBERSOL | tuberculin, purified protein derivative | Injection | 103941 | 02/24/2000 | ⤷ Try a Trial | 2040-01-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |